Device Trial Radar · NCT02278107
Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease
Last checked: Nov 20, 2026Latest source record: Feb 29, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
20
Planned (sponsor's estimate)
Start
Jul 2014
Primary completion
Dec 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- New Aera, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 29, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Supportive care
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A preliminary study to evaluate a new nasal interface and portable ventilator system in comparison to standard oxygen therapy in patients with severe chronic lung disease.
Conditions
- Chronic Obstructive Lung Disease
- Interstitial Lung Disease
Interventions
Tidal Assist Ventilator SystemDevice
Tidal volume augmentation with supplemental oxygen. Source gas options: cylinder, concentrator, wall.
Nasal Cannula OxygenDevice
Standard oxygen therapy delivered by nasal cannula at 2-5 lpm based on patient requirements. Source gas options: cylinder, concentrator, wall.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Exercise Endurance Time to Maximum ToleranceTime frame: Maximum exercise endurance in minutes, for both treatment arms. Two 4-hr study visits, 1 week apart. Endurance endpoint will be evaluated during a single 4-hr period on Study Visit 2. Each exercise test will be separated by a 1.5 hr rest period.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.